|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
92:11721-11725
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
|
|
J.B.Charbonnier,
E.Carpenter,
B.Gigant,
B.Golinelli-Pimpaneau,
Z.Eshhar,
B.S.Green,
M.Knossow.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The x-ray structure of the complex of a catalytic antibody Fab fragment with a
phosphonate transition-state analog has been determined. The antibody (CNJ206)
catalyzes the hydrolysis of p-nitrophenyl esters with significant rate
enhancement and substrate specificity. Comparison of this structure with that of
the uncomplexed Fab fragment suggests hapten-induced conformational changes: the
shape of the combining site changes from a shallow groove in the uncomplexed Fab
to a deep pocket where the hapten is buried. Three hydrogen-bond donors appear
to stabilize the charged phosphonate group of the hapten: two NH groups of the
heavy (H) chain complementarity-determining region 3 (H3 CDR) polypeptide chain
and the side-chain of histidine-H35 in the H chain (His-H35) in the H1 CDR. The
combining site shows striking structural similarities to that of antibody 17E8,
which also has esterase activity. Both catalytic antibody ("abzyme")
structures suggest that oxyanion stabilization plays a significant role in their
rate acceleration. Additional catalytic groups that improve efficiency are not
necessarily induced by the eliciting hapten; these groups may occur because of
the variability in the combining sites of different monoclonal antibodies that
bind to the same hapten.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
I.C.Wilkinson,
C.J.Hall,
V.Veverka,
J.Y.Shi,
F.W.Muskett,
P.E.Stephens,
R.J.Taylor,
A.J.Henry,
and
M.D.Carr
(2009).
High resolution NMR-based model for the structure of a scFv-IL-1beta complex: potential for NMR as a key tool in therapeutic antibody design and development.
|
| |
J Biol Chem,
284,
31928-31935.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.W.Debler,
R.Müller,
D.Hilvert,
and
I.A.Wilson
(2008).
Conformational isomerism can limit antibody catalysis.
|
| |
J Biol Chem,
283,
16554-16560.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.W.Debler,
G.F.Kaufmann,
R.N.Kirchdoerfer,
J.M.Mee,
K.D.Janda,
and
I.A.Wilson
(2007).
Crystal structures of a quorum-quenching antibody.
|
| |
J Mol Biol,
368,
1392-1402.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Racape,
F.Connan,
J.Hoebeke,
J.Choppin,
and
J.G.Guillet
(2006).
Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.
|
| |
Proc Natl Acad Sci U S A,
103,
18208-18213.
|
 |
|
|
|
|
 |
J.L.Pellequer,
S.W.Chen,
Y.S.Keum,
A.E.Karu,
Q.X.Li,
and
V.A.Roberts
(2005).
Structural basis for preferential binding of non-ortho-substituted polychlorinated biphenyls by the monoclonal antibody S2B1.
|
| |
J Mol Recognit,
18,
282-294.
|
 |
|
|
|
|
 |
T.A.Muranova,
S.N.Ruzheinikov,
S.E.Sedelnikova,
A.Moir,
L.J.Partridge,
H.Kakinuma,
N.Takahashi,
K.Shimazaki,
J.Sun,
Y.Nishi,
and
D.W.Rice
(2001).
The preparation and crystallization of Fab fragments of a family of mouse esterolytic catalytic antibodies and their complexes with a transition-state analogue.
|
| |
Acta Crystallogr D Biol Crystallogr,
57,
1192-1195.
|
 |
|
|
|
|
 |
T.Tsumuraya,
N.Takazawa,
A.Tsunakawa,
R.Fleck,
and
S.Masamune
(2001).
Catalytic antibodies induced by a zwitterionic hapten.
|
| |
Chemistry,
7,
3748-3755.
|
 |
|
|
|
|
 |
A.V.Kolesnikov,
A.V.Kozyr,
E.S.Alexandrova,
F.Koralewski,
A.V.Demin,
M.I.Titov,
B.Avalle,
A.Tramontano,
S.Paul,
D.Thomas,
A.G.Gabibov,
and
A.Friboulet
(2000).
Enzyme mimicry by the antiidiotypic antibody approach.
|
| |
Proc Natl Acad Sci U S A,
97,
13526-13531.
|
 |
|
|
|
|
 |
B.Golinelli-Pimpaneau,
O.Goncalves,
T.Dintinger,
D.Blanchard,
M.Knossow,
and
C.Tellier
(2000).
Structural evidence for a programmed general base in the active site of a catalytic antibody.
|
| |
Proc Natl Acad Sci U S A,
97,
9892-9895.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Golinelli-Pimpaneau
(2000).
Novel reactions catalysed by antibodies.
|
| |
Curr Opin Struct Biol,
10,
697-708.
|
 |
|
|
|
|
 |
D.Hilvert
(2000).
Critical analysis of antibody catalysis.
|
| |
Annu Rev Biochem,
69,
751-793.
|
 |
|
|
|
|
 |
B.Avalle,
V.Zanin,
D.Thomas,
and
A.Friboulet
(1998).
Antibody catalysis based on functional mimicry.
|
| |
Appl Biochem Biotechnol,
75,
3.
|
 |
|
|
|
|
 |
A.Persidis
(1997).
Catalytic antibodies. Some companies are taking an active interest in this promising technology.
|
| |
Nat Biotechnol,
15,
1313-1315.
|
 |
|
|
|
|
 |
B.Gigant,
J.B.Charbonnier,
B.Golinelli-Pimpaneau,
R.R.Zemel,
Z.Eshhar,
B.S.Green,
and
M.Knossow
(1997).
Mechanism of inactivation of a catalytic antibody by p-nitrophenyl esters.
|
| |
Eur J Biochem,
246,
471-476.
|
 |
|
|
|
|
 |
B.Gigant,
J.B.Charbonnier,
Z.Eshhar,
B.S.Green,
and
M.Knossow
(1997).
X-ray structures of a hydrolytic antibody and of complexes elucidate catalytic pathway from substrate binding and transition state stabilization through water attack and product release.
|
| |
Proc Natl Acad Sci U S A,
94,
7857-7861.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Wade,
and
T.S.Scanlan
(1997).
The structural and functional basis of antibody catalysis.
|
| |
Annu Rev Biophys Biomol Struct,
26,
461-493.
|
 |
|
|
|
|
 |
J.B.Charbonnier,
B.Golinelli-Pimpaneau,
B.Gigant,
D.S.Tawfik,
R.Chap,
D.G.Schindler,
S.H.Kim,
B.S.Green,
Z.Eshhar,
and
M.Knossow
(1997).
Structural convergence in the active sites of a family of catalytic antibodies.
|
| |
Science,
275,
1140-1142.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.C.Hsieh-Wilson,
P.G.Schultz,
and
R.C.Stevens
(1996).
Insights into antibody catalysis: structure of an oxygenation catalyst at 1.9-angstrom resolution.
|
| |
Proc Natl Acad Sci U S A,
93,
5363-5367.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |